NDC 55466-149-22 - Oseltamivir Phosphate
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 55466-149
- Requested NDC
- 55466-149-22
- Package NDCs from labels
- 55466-149-22
- Manufacturer
- Neolpharma, Inc.
- Effective date
- 2024-05-24
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Oseltamivir Phosphate - Neolpharma, Inc. | Neolpharma, Inc. | 2024-05-24 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 55466-149-22 | Oseltamivir Phosphate | 10 in 1 BOTTLE | CAPSULE | 10 | 5 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Oseltamivir Phosphate | OSELTAMIVIR PHOSPHATE | Strides Pharma Science Limited | f26154bd-374c-44a8-983a-b2724a591653 | 2026-09-08 | Warnings, Adverse reactions | 728113 312122 728109 4A3O49NGEZ |
| OSELTAMIVIR PHOSPHATE | OSELTAMIVIR PHOSPHATE | Leading Pharma, LLC | ef093e4d-5b1a-463f-a1a3-b795a4387a81 | 2026-08-24 | Warnings, Adverse reactions | 4A3O49NGEZ |
| Oseltamivir Phosphate | OSELTAMIVIR PHOSPHATE | Preferred Pharmaceuticals Inc. | b1abef84-d074-4872-9193-48a52cbabbd6 | 2026-08-10 | Warnings, Adverse reactions | 4A3O49NGEZ |
| Oseltamivir phosphate | OSELTAMIVIR PHOSPHATE | Preferred Pharmaceuticals Inc. | 817f74ca-2b6d-4d29-8dd5-b96921a23b91 | 2026-08-10 | Warnings, Adverse reactions | 312122 4A3O49NGEZ |
| Oseltamivir Phosphate | OSELTAMIVIR PHOSPHATE | Preferred Pharmaceuticals Inc. | 89a3539b-a067-4073-b7a0-d04e7f130396 | 2026-08-07 | Warnings, Adverse reactions | 312122 4A3O49NGEZ |
| OSELTAMIVIR PHOSPHATE | OSELTAMIVIR PHOSPHATE | Aurobindo Pharma Limited | 07958a9a-2360-4380-b7da-5371ed80a271 | 2026-08-07 | Warnings, Adverse reactions | 4A3O49NGEZ |
| Oseltamivir Phosphate | OSELTAMIVIR PHOSPHATE | A-S Medication Solutions | e1bec65b-4292-4110-a840-aa48053b5448 | 2026-07-23 | Warnings, Adverse reactions | 312122 4A3O49NGEZ |
| 5697d499-39f6-7721-e063-6394a90a3c25 | ee8a95c3-df9d-6e55-e053-2a95a90ab17b | 2026-07-14 | Warnings, Adverse reactions | ee8a95c3-df9d-6e55-e053-2a95a90ab17b | ||
| Oseltamivir Phosphate | OSELTAMIVIR PHOSPHATE | Alvogen Inc. | 809f859e-0852-80d3-1a67-da87ed399c15 | 2026-07-06 | Warnings, Adverse reactions | 728113 312122 728109 4A3O49NGEZ |
| OSELTAMIVIR PHOSPHATE | OSELTAMIVIR PHOSPHATE | Alembic Pharmaceuticals Inc. | 379f59fe-22d9-4bac-b9b5-31fdaebbd923 | 2026-06-29 | Warnings, Adverse reactions | 4A3O49NGEZ |
| Oseltamivir | OSELTAMIVIR PHOSPHATE | Laurus Labs Limited | 927cba3a-62cf-4e9f-9871-92835927ea46 | 2026-06-19 | Warnings, Adverse reactions | 728113 312122 728109 4A3O49NGEZ |
| Oseltamivir phosphate | OSELTAMIVIR PHOSPHATE | REMEDYREPACK INC. | ad765459-e0d2-418e-8bae-8f6d16dfc1d8 | 2026-06-11 | Warnings, Adverse reactions | 312122 4A3O49NGEZ |
| Oseltamivir phosphate | OSELTAMIVIR PHOSPHATE | Shandong New Time Pharmaceutical Co., Ltd. | 61b673d9-4787-4bc8-bf9e-2cfef0326911 | 2026-06-07 | Warnings, Adverse reactions | 728113 312122 728109 4A3O49NGEZ |
| Oseltamivir Phosphate | OSELTAMIVIR PHOSPHATE | HEC Pharm USA Inc. | 4dd9214a-6b7f-efe9-e063-6294a90ac4fb | 2026-06-01 | Warnings, Adverse reactions | 4A3O49NGEZ |
| Oseltamivir Phosphate | OSELTAMIVIR PHOSPHATE | Sportpharm LLC | a8a40f98-f6bd-4ef0-af03-93ed0f473c10 | 2026-04-24 | Warnings, Adverse reactions | 728113 312122 728109 4A3O49NGEZ |
| Caldesene Baby | STARCH, CORN AND ZINC OXIDE | Insight Pharmaceuticals LLC | 9f12dee2-7afa-45e9-a729-0fd42bb77715 | 2026-04-22 | Warnings | O8232NY3SJ |
| Caldesene Medicated Protecting | CORNSTARCH AND ZINC OXIDE | Insight Pharmaceuticals LLC | ffc92a0f-a7cf-4a46-b2f1-089df2bbb96b | 2026-04-22 | Warnings | O8232NY3SJ |
| OSELTAMIVIR PHOSPHATE | OSELTAMIVIR PHOSPHATE | Alembic Pharmaceuticals Limited | a70d9914-078f-4b4d-a1be-04669f7d0878 | 2026-03-22 | Warnings, Adverse reactions | 4A3O49NGEZ |
| Oseltamivir Phosphate | OSELTAMIVIR PHOSPHATE | REMEDYREPACK INC. | ad90fe42-8d52-403e-9b07-b8536fbf335a | 2026-03-13 | Warnings, Adverse reactions | 312122 4A3O49NGEZ |
| Oseltamivir Phosphate | OSELTAMIVIR PHOSPHATE | Sportpharm LLC | 92726a00-4237-49fd-9e29-5d4f5f999874 | 2026-02-11 | Warnings, Adverse reactions | 728113 312122 728109 4A3O49NGEZ |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.